The PROTECT Study: A phase II, open-label trial of prophylactic skin toxicity therapy with clindamycin and triamcinolone in patients with glioblastoma treated with tumortreating fields

Category Primary study
JournalJournal of Clinical Oncology
Year 2022
This article has no abstract
Epistemonikos ID: 14d88ce10d5c1a678408c02bc37b8b8bf39e9332
First added on: Feb 14, 2025